Close

Aviragen Therapeutics (AVIR) Delays Q4 Conference Call

Go back to Aviragen Therapeutics (AVIR) Delays Q4 Conference Call

Aviragen Therapeutics Announces Schedule Change for Fourth Quarter and Fiscal Year End 2016 Financial Results Conference Call and Webcast

September 6, 2016 5:34 PM EDT

ATLANTA, Sept. 06, 2016 (GLOBE NEWSWIRE) -- Aviragen Therapeutics, Inc. (NASDAQ: AVIR), (formerly Biota Pharmaceuticals, Inc.), a pharmaceutical company that is developing the next generation of antivirals, announced today that it is delaying the time of its fourth quarter and fiscal year end 2016 earnings conference call and webcast while it concludes discussions involving the... More